2019 Mar – 2024 Feb | $7.09M

Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali

Similar Posts

  • 2019 Mar – 2024 Feb | $11.4M

    Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…

  • 2017 Jun – 2019 May

    Characterization of Plasmodium falciparum gametocytes infectiousness determinants in Mali University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Dinkorma Ouologuem | Africa, Central, Africa, Eastern, Africa, Southern, Mali

  • 2021 Jan – 2024 Jan

    Increasing the uptake of IPTp-SP through Seasonal Malaria Chemoprevention channel delivery (INTEGRATION study) R-Evolution Worldwide, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali, Research Institute of Health Sciences (IRSS), Burkina Faso | Kassoum Kayentao | Burkina Faso, Mali

  • 2019 Mar – 2023 Feb | $7.64M

    Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children (ASAAP) European & Developing Countries Clinical Trials Partnership (EDCTP), Kwame Nkrumah University of Science and Technology, Kumasi, Ghana | Oumou Maiga-Ascofare | Gabon, Benin, Burkina Faso, Guinea, Mali

  • PYRAPREG

    Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…

Leave a Reply

Your email address will not be published. Required fields are marked *